Analyst Ratings for Valeant Pharmaceuticals (vrx)

vrx Rating Summary

vrx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on vrx
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $182.00 (-7.8%) * Over Last 12-Mos
Rating Score: 8.2 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
2/9/2015 Barclays New Coverage Overweight
(N/A)
200.00
(N/A)
161.99 197.39 21.85% Details
12/1/2014 Goldman Sachs New Coverage Buy
(N/A)
178.00
(N/A)
145.45 197.39 35.71% Details
Like VRX Ratings? Also take a look at AGN, SLXP, ENDP, ACT

VRX Ratings News